Point Of Care Diagnostics 2010 And Beyond: Rapid Testing At A Crossroads
As Kalorama Information’s lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready?
Kalorama believes that the drive for wellness and the attention surrounding healthcare reform will focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M.B.A., there are many challenges which must be overcome for point of care solutions to be fully utilized, and those companies willing to pivot strategies and best adjust to tomorrow’s healthcare marketplace may be rewarded.
This report, Point of Care Diagnostics 2010: Rapid Testing at a Crossroads represents the most current analysis of the role POC Diagnostics in today’s in vitro industry. Other reports have looked at products, companies and revenue numbers, as this report does. But in her analysis Shara Rosen takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. The report includes:
Markets for POC Diagnostics (Diabetes, Cardiac markers, Clinical Chemistry/Critical Care, Hematology, Coagulation, Drugs of Abuse/Therapeutic Drug Monitoring, Infectious Diseases, Pharmacodiagnostics, Sepsis, Oncology, Women’s health / Pregnancy/Fertility)
By Venue Revenue Estimates for Hospital POC, Physician POC and Other Venue
Review of Products in the Market
Forecasts to 2013
Markets and Forecasts for Self-Testing (OTC)
The role of EMR in the Point of Care Market
Possible Effects of Healthcare Reform
POLs, Home Monitoring, Alternate Samples and Other Trends
Successful Strategies of POC Companies
Profiles of Over 100 Companies Competing in this Market
There are many factors in the growth of POC testing- increasing numbers of diagnosed diabetics, people with cardiovascular disease, and other chronic conditions. It is also expected to play a role in a trend in health care to evaluate provider organizations for quality in care delivery. While this quality imperative is most apparent in pay-for-performance systems, it also provides a framework by which public funds can be used more rationally. This is an especially relevant technology given the U.S. healthcare reform efforts.
All countries are feeling the brunt of aging populations and an increased burden of chronic disease management. Employers and insurance companies are interested in improving the health of customers, and there are some innovative tactics developing in this area. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.
The report offers a quantitative assessment of specific markets in US dollars for 2008 and forecasted out to 2013. These data are provided in order to set the status quo of tests and technologies. However the report concentrates on how these will impact the economics of healthcare over the near term and longer when possible.
As part of Kalorama Information’s comprehensive coverage, the following companies are discussed:
23andMe
3M Health Care
77 Elektronika
A. Menarini
A/C Diagnostics
Abaxis, Inc.
Abbott Diagnostics
ABTECH Scientific
Accumetrics
ACIST Medical
Acrongenomics Inc.
Adeza Biomedical
ADIATEC
Aerscher Diagnostics
AgaMatrix, Inc.
Alfa Scientific
Alfa Wassermann
Alverix Inc.
American Bio Medica
Amic/Ortho
Amnisure International
Animas/J&J
ANP Technologies
Antigen Discovery Inc.
Apollo Hospitals
Arkray
Arrayit Diagnostics
AspenBio Pharma
Astron Clinica
AT First Diagnostic
Audit Diagnostics
Axis-Shield plc
Bayer Diabetes Care
Beckman Coulter
Becton Dickinson
Bedfont Scientific
Biohit Oy
BioIQ
bioLytical Labs
Biomagnetics Diagnostics
Biomerica, Inc.
bioMérieux
Bionime Corp.
Bio-Rad Laboratories
BIOSAFE Medical Technologies
Biosite/Inverness
Boditech Med
BodyTel Scientific
Branan Medical Corp
Burnet Institute
Calypte Biomedical
Careside Medical
Carolina Liquid Chemistries
Celerus Diagnostics
Chelsea Technologies
Chembio Diagnostic
Chempaq A/S
Chemtron Biotech
Cholestech Corp.
Claros Diagnostics
CLX Medical, Inc.
Combimatrix
Common Sense, Ltd.
Commonwealth Labs
Connectyx Technologies
ContraVac, Inc.
Decision Biomarkers
DexCom, Inc.
Diabetech, LP
Diabetes Sentry
Diaglobal GmbH
Diagnostic Devices
Diagnostics for All
Diagnostics for the Real World
Diazyme Laboratories
Digital Bio Tech
Diversa Limited
DNA Direct, Inc.
DNAFORM
DxNA
Echo Therapeutics
EKF-diagnostic GmbH
Enfora
Enigma Diagnostics
Enterix Inc.
Entra Health
Epocal, Inc.
EPS Bio Technology
ESA Biosciences
eScreen, Inc.
ExpressMD Solutions
EyeMarker Systems
Flexsite Diagnostics
Focus Diagnostics
Fora Care
GE Healthcare
GenBio
Gene Smart Wellness
Genexel-Sein Inc.
Gentag Inc.
Genzyme Diagnostics
Global Detection & Reporting
Glucometrics, Inc.
Google, Inc.
Guided Therapeutics
Hai Kang Life Corp.
Hain Lifescience GmbH
HandyLab, Inc.
HealthPia America
HealthPort
Helena Laboratories
Hema Diagnostic Systems
Hema Metrics
HemoCue AB
Hero Network Network
HMM GmbH
Hoana Medical
Home Access Health
Home Diagnostics
Horiba ABX
Idaho Technology
IDenta Corp
Identigene
IDEXX Laboratories
incentaHEALTH LLC
Innovative Biosensors
Instrumentation Laboratory
Insulet Corporation
Integrity Applications
Intel Corporation
International Technidyne
Inverness Medical Innovations
Knome
Lab Express
LifeAssays AB
Lifescan
LifeSign LLC
LifeStat
Lifestream Technologies, Inc.
Lifestyle Choices
Luminex
Luminous Medical
MACHEREY-NAGEL
Masimo Corp
Matritech
M-Biotech
Medical Automation Systems
MedMira Inc.
Medtronic Inc.
Menssana Research, Inc.
Meretek Diagnostics Inc.
Meridian Bioscience
Micromem Technologies
Micronics Inc.
MicroPhage, Inc.
MinuteClinic
Mitsubishi Kagaku Iatron
MP Biomedicals
Multilyte Limited
MycroLab Pty
Nanogen
Nanomix, Inc.
Nanosphere, Inc.
National Jewish Health
Navigenics, Inc.
Network Biosystems
Neuroptix Corp
Nihon Kohden
Noninvasive Medical Tech
Nova Biomedical
OPTI Medical Systems
OraSure Technologies
Orion Diagnostica
OrSense Ltd.
Ortho Clinical Diagnostics
OvumOptics, Inc.
Oxford Biosensors
Oxonica Diagnostics
Phadia AB
Philips Handheld Immunoassays
PlaCor, Inc.
PointCare Technologies
Polymedco
Practice Fusion
PreMD Inc.
PrimeraDx
Probe Scientific Ltd
Prometheus Laboratories
Psynomics
QBC Diagnostics
Qiagen
Q-linea
Quadraspec
QualSec, Inc
QuantRx Biomedical Corporation
Quidel Corp
Quotient Diagnostics
Radiometer A/S
Raman spectroscopy
Rapid Pathogen Screening
Rennesens GmbH
Response Biomedical
Rite Aid
Roche Diagnostics
Royal Philips Electronics
Safeway, Inc.
Screening Devices Canada
SEMOFS
Sentinel Bioactive Paper Network
SeraCare Life Sciences
Serotec
Siemens Healthcare Diagnostics
SIENCO
Smiths Detection
Smiths Medical MD
Soar BioDynamics
Solei Systems, Inc
Solianis Monitoring
SpectraScience, Inc.
Sphere Medical Ltd.
SpheroSense Technologies
Stanbio Laboratory
StatSure Diagnostic Systems
STD Test Express
STMicroelectronics
Synova Healthcare
Sysmex Corp
T2 Biosystems
Taidoc Technology
TelCare
Telus Corporation
Textronics, Inc.
Thermo Fisher Scientific
Tosoh Corp
Trinity Biotech
TwistDx, Ltd.
Tyrian Diagnostics
UnitedHealth Group
Veralight, Inc.
Veredus Laboratories
VeriChip Corporation
Via Medical Corp
Vital Diagnostics
Vivacta Limited
Walgreens
Wal-Mart Stores
Webahn Inc.
Ypsomed
To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1660/Point-of-Care-Diagnostics-2010-and-Beyond-Rapid-Testing-at-a-Crossroads.html
Contact us:
Visionshopsters
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com
VisionShopsters.com specializes in providing comprehensive collection of online market research reports, conference/events/seminars bookings, country reports, company profiles, latest books and magazines, customized research services offering informative solutions worldwide. We constantly believe in providing inventive solutions to clients all across the globe.
